Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07664527 · ClinicalTrials.gov registry record · Phase 4
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Not yet
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT07664527 is a Phase 4 study that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants.
The verdict
NCT07664527, a Phase 4 study, has not yet begun recruiting, sponsored by University of Wisconsin, Madison.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is to find out if an Extra Virgin Olive-Oil-based Water (EVOOW) mix, removes more Fluticasone Propionate (FP) from the mouth than Water alone. 2 strengths of the EVOOW mix will be tested, one with equal parts EVOO and Water (50/50) and one with 3 parts EVOO and 1 part Water (75/25). Removing more FP deposits may help decrease the risk for obstructive sleep apnea (OSA), candidiasis (thrush), and speech and swallow dysfunction. Participants will be on study for up to 3 weeks.
Interventions
- DRUG Fluticasone Propionate
- OTHER Water Mouthwash
- OTHER EVOOW Mouthwash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07664527
The ClinicalTrials.gov registry entry for NCT07664527 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fluticasone Propionate is the first listed.
NCT07664527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07664527 about?
NCT07664527 is a clinical study titled "Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate". This study is to find out if an Extra Virgin Olive-Oil-based Water (EVOOW) mix, removes more Fluticasone Propionate (FP) from the mouth than Water alone. 2 strengths of the EVOOW mix will be tested, one with equal parts EVOO and Water (50/50) and one with 3 parts EVOO and 1 part Water (75/25). Remov...
What is the current status of trial NCT07664527?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2026-07. Estimated completion is 2027-04.
What interventions are being tested in trial NCT07664527?
The interventions under investigation include: Fluticasone Propionate (DRUG), Water Mouthwash (OTHER), EVOOW Mouthwash (OTHER).
Who is sponsoring clinical trial NCT07664527?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.